Novo Nordisk Hit by U.S. Delay to New Insulin Drug

08.06.2012 - Danish drugmaker Novo Nordisk , the world's biggest insulin maker, said on Friday that U.S. health regulators had extended their review of its new ultra-long-acting insulin Tresiba...